Nirsevimab Against Hospitalizations and Emergency Department Visits for Lower Respiratory Tract Infection in Infants
In this meta-analysis, nirsevimab was associated with reduced LRTI-related hospitalizations and ED visits in infants and young children. These findings support nirsevimab's potential to reduce respiratory-related morbidity in young children and health care utilization.
Authors
- Seyed M. Moghadas (ORCID: https://orcid.org/0000-0003-4414-0227)
- Dewan Md. Sumsuzzman (ORCID: https://orcid.org/0000-0002-4468-1202)
- Joanne M. Langley (ORCID: https://orcid.org/0000-0003-3270-7345)
- Congjie Shi
Institutions
- Dalhousie University (CA)
- York University (CA)
- Izaak Walton Killam Health Centre (CA)
- Nova Scotia Health Authority (CA)
Publication Details
- Journal
- JAMA Pediatrics
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1001/jamapediatrics.2025.5280
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00